These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2416518)

  • 1. In vivo effects of the insulin-like growth factors (IGFs) in the hypophysectomized rat: comparison with human growth hormone and the possible role of the specific IGF carrier proteins.
    Zapf J; Schoenle E; Froesch ER
    Ciba Found Symp; 1985; 116():169-87. PubMed ID: 2416518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats.
    Zapf J; Hauri C; Waldvogel M; Futo E; Häsler H; Binz K; Guler HP; Schmid C; Froesch ER
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3813-7. PubMed ID: 2471192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF-binding proteins in serum.
    Clemmons DR; Thissen JP; Maes M; Ketelslegers JM; Underwood LE
    Endocrinology; 1989 Dec; 125(6):2967-72. PubMed ID: 2479531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
    Glasscock GF; Hein AN; Miller JA; Hintz RL; Rosenfeld RG
    Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats.
    Schoenle E; Zapf J; Hauri C; Steiner T; Froesch ER
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):167-74. PubMed ID: 3881885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human insulin-like growth factor: testing the somatomedin hypothesis in hypophysectomized rats.
    Skottner A; Clark RG; Robinson IC; Fryklund L
    J Endocrinol; 1987 Jan; 112(1):123-32. PubMed ID: 3819627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats.
    Zapf J; Hauri C; Waldvogel M; Froesch ER
    J Clin Invest; 1986 Jun; 77(6):1768-75. PubMed ID: 3711334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone, but not insulin-like growth factor I, induces a serum protease activity for insulin-like growth factor binding protein-3 in hypophysectomized rats in vivo.
    Rutishauser J; Schmid C; Hauri C; Froesch ER; Zapf J
    FEBS Lett; 1993 Nov; 334(1):23-6. PubMed ID: 7693512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of pituitary regulation of growth in the developing rat: comparison of effects of hypophysectomy and hormone replacement on somatic and organ growth, serum insulin-like growth factor-I (IGF-I) and IGF-II levels, and IGF-binding protein levels in the neonatal and juvenile rat.
    Glasscock GF; Gin KK; Kim JD; Hintz RL; Rosenfeld RG
    Endocrinology; 1991 Feb; 128(2):1036-47. PubMed ID: 1703478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
    Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
    Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice.
    van Buul-Offers SC; Reijnen-Gresnigt MG; Hoogerbrugge CM; Bloemen RJ; Kuper CF; Van den Brande JL
    Endocrinology; 1994 Sep; 135(3):977-85. PubMed ID: 7520865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
    Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D
    Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone dependence of somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II messenger ribonucleic acids.
    Hynes MA; Van Wyk JJ; Brooks PJ; D'Ercole AJ; Jansen M; Lund PK
    Mol Endocrinol; 1987 Mar; 1(3):233-42. PubMed ID: 3453890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats.
    Kurtz A; Zapf J; Eckardt KU; Clemons G; Froesch ER; Bauer C
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7825-9. PubMed ID: 3174666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Several insulin-like growth factor-I analogues and complexes of insulin-like growth factors-I and -II with insulin-like growth factor-binding protein-3 fail to mimic the effect of growth hormone upon lactation in the rat.
    Flint DJ; Tonner E; Beattie J; Gardner M
    J Endocrinol; 1994 Feb; 140(2):211-6. PubMed ID: 7513341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of sulfate and thymidine incorporation into hypophysectomized rat cartilage by growth hormone and insulin-like growth factor-I in vitro: the somatomedin hypothesis revisited.
    Salmon WD; Burkhalter VJ
    J Lab Clin Med; 1997 Apr; 129(4):430-8. PubMed ID: 9104886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone.
    Gosteli-Peter MA; Winterhalter KH; Schmid C; Froesch ER; Zapf J
    Endocrinology; 1994 Dec; 135(6):2558-67. PubMed ID: 7527334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL; Casinghino S; Centrella M; Canalis E
    J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia.
    Zapf J; Schmid C; Guler HP; Waldvogel M; Hauri C; Futo E; Hossenlopp P; Binoux M; Froesch ER
    J Clin Invest; 1990 Sep; 86(3):952-61. PubMed ID: 1697608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of insulin--like growth factor-I treatment on the endocrine pancreas of hypophysectomized rats: comparison with growth hormone replacement.
    Jevdjovic T; Maake C; Eppler E; Zoidis E; Reinecke M; Zapf J
    Eur J Endocrinol; 2004 Aug; 151(2):223-31. PubMed ID: 15296478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.